3 Key Things to Know About How the Mylan-Upjohn Merger Affects Pfizer Shareholders

Those rumors that floated over the weekend that Pfizer (NYSE: PFE) was about to make a big deal with Mylan (NASDAQ: MYL) proved to be true. On Monday, Pfizer and Mylan announced that they plan to merge Pfizer's Upjohn unit with Mylan. 

While Mylan's shares jumped on the news, Pfizer stock slipped a little on Monday. What does the Mylan-Upjohn merger mean for Pfizer shareholders? It's complicated, but there are three important things to know. 

Image source: Getty Images.

Continue reading

Quelle Fool.com